These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23471446)

  • 1. HIV treatment as prevention: population effect vs. individual protection?
    Ippolito G; Rezza G
    Ann Ig; 2013; 25(2):93-7. PubMed ID: 23471446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethics of ARV based prevention: treatment-as-prevention and PrEP.
    Haire B; Kaldor JM
    Dev World Bioeth; 2013 Aug; 13(2):63-9. PubMed ID: 23594312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vulnerable infected populations and street markets for ARVs: Potential implications for PrEP rollout in the USA.
    Kurtz SP; Buttram ME; Surratt HL
    AIDS Care; 2014 Apr; 26(4):411-5. PubMed ID: 24033118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preexposure prophylaxis for the prevention of HIV transmission to women.
    Aaron E; Cohan D
    AIDS; 2013 Jan; 27(1):F1-5. PubMed ID: 22914582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Where to deploy pre-exposure prophylaxis (PrEP) in sub-Saharan Africa?
    Verguet S; Stalcup M; Walsh JA
    Sex Transm Infect; 2013 Dec; 89(8):628-34. PubMed ID: 23912819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
    Panel de expertos de GESIDA y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of pre-exposure prophylaxis for HIV: a review.
    Schackman BR; Eggman AA
    Curr Opin HIV AIDS; 2012 Nov; 7(6):587-92. PubMed ID: 23076124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Untangling the cost-effectiveness knot: who is oral antiretroviral HIV pre-exposure prophylaxis really for?
    Hankins CA
    Expert Rev Pharmacoecon Outcomes Res; 2014 Apr; 14(2):167-70. PubMed ID: 24552641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV exposure through contact with body fluids.
    Prescrire Int; 2012 Apr; 21(126):100-1, 103-5. PubMed ID: 22515138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparing for PrEP.
    Lacor P
    Eur J Contracept Reprod Health Care; 2012 Dec; 17(6):482-6. PubMed ID: 23113873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antiretroviral drugs-based HIV prevention methods: what impact on the HIV epidemic?].
    Supervie V
    Med Sci (Paris); 2013 Apr; 29(4):373-82. PubMed ID: 23621932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The promise of pre-exposure prophylaxis with antiretroviral drugs to prevent HIV transmission: a review.
    Hankins CA; Dybul MR
    Curr Opin HIV AIDS; 2013 Jan; 8(1):50-8. PubMed ID: 23201856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the place of pre-exposure prophylaxis in HIV prevention?
    De Man J; Colebunders R; Florence E; Laga M; Kenyon C
    AIDS Rev; 2013; 15(2):102-11. PubMed ID: 23685443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic preexposure prophylaxis for human immunodeficiency virus infection.
    Romanelli F; Murphy B
    Pharmacotherapy; 2010 Oct; 30(10):1021-30. PubMed ID: 20874040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-exposure prophylaxis for HIV infection.
    Rey D
    Expert Rev Anti Infect Ther; 2011 Apr; 9(4):431-42. PubMed ID: 21504400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reduction of mother-child transmission of HIV infection in Africa: from clinical research to public health programs].
    Leroy V; Dabis F
    Med Trop (Mars); 1999; 59(4 Pt 2):456-64. PubMed ID: 10901847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and effectiveness of antiretroviral drugs during pregnancy, delivery and breastfeeding for prevention of mother-to-child transmission of HIV-1: the Kesho Bora Multicentre Collaborative Study rationale, design, and implementation challenges.
    Kesho Bora Study Group
    Contemp Clin Trials; 2011 Jan; 32(1):74-85. PubMed ID: 20854932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbicides-emerging essential pillars of comprehensive HIV/AIDS prevention.
    Gaym A
    Ethiop Med J; 2006 Oct; 44(4):405-15. PubMed ID: 17370443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.